Illumina (ILMN) News Today $136.67 -0.70 (-0.51%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Illumina, Inc. (NASDAQ:ILMN) Receives Consensus Rating of "Moderate Buy" from BrokeragesIllumina, Inc. (NASDAQ:ILMN - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the twenty brokerages that are covering the stock, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold recommendation, ten have given a buy recJanuary 20 at 2:12 AM | marketbeat.comSax Wealth Advisors LLC Purchases Shares of 4,198 Illumina, Inc. (NASDAQ:ILMN)Sax Wealth Advisors LLC acquired a new position in shares of Illumina, Inc. (NASDAQ:ILMN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 4,198 shares of the life sciences company's stock,January 19 at 4:49 AM | marketbeat.com17,599 Shares in Illumina, Inc. (NASDAQ:ILMN) Bought by Avanza Fonder ABAvanza Fonder AB purchased a new stake in Illumina, Inc. (NASDAQ:ILMN - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 17,599 shares of the life sciences company's stock, valued at approximately $2,352,000. Several othJanuary 19 at 4:18 AM | marketbeat.comGateway Investment Advisers LLC Raises Position in Illumina, Inc. (NASDAQ:ILMN)Gateway Investment Advisers LLC lifted its stake in shares of Illumina, Inc. (NASDAQ:ILMN - Free Report) by 8.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 29,463 shares of the life sciences company's stock after acJanuary 18 at 4:08 AM | marketbeat.comIllumina’s Promising Growth Trajectory: Buy Rating Backed by Strategic Positioning and Market InnovationsJanuary 17 at 4:34 PM | markets.businessinsider.comSicart Associates LLC Trims Stock Position in Illumina, Inc. (NASDAQ:ILMN)Sicart Associates LLC lowered its holdings in shares of Illumina, Inc. (NASDAQ:ILMN - Free Report) by 5.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 60,685 shares of the life sciences company's stock after selling 3,177January 17 at 6:06 AM | marketbeat.comIllumina, Inc. (ILMN) Stock ForecastsJanuary 17 at 2:40 AM | ca.finance.yahoo.comRoyal Caribbean Group's Artist Discovery Program to Illuminate Star of the SeasJanuary 16, 2025 | gurufocus.comBeech Hill Advisors Inc. Has $1.92 Million Stock Holdings in Illumina, Inc. (NASDAQ:ILMN)Beech Hill Advisors Inc. boosted its position in Illumina, Inc. (NASDAQ:ILMN - Free Report) by 86.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,349 shares of the life sciences company's stock afterJanuary 16, 2025 | marketbeat.comIllumina, Inc. (NASDAQ:ILMN) Short Interest UpdateIllumina, Inc. (NASDAQ:ILMN - Get Free Report) saw a large decrease in short interest in December. As of December 31st, there was short interest totalling 5,040,000 shares, a decrease of 22.6% from the December 15th total of 6,510,000 shares. Based on an average trading volume of 2,000,000 shares, the days-to-cover ratio is currently 2.5 days.January 16, 2025 | marketbeat.com10,833 Shares in Illumina, Inc. (NASDAQ:ILMN) Acquired by USA Financial FormulasUSA Financial Formulas bought a new position in Illumina, Inc. (NASDAQ:ILMN - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 10,833 shares of the life sciences company's stock, valued at approximately $1,448,000. Illumina comprises approximJanuary 16, 2025 | marketbeat.comIllumina (NASDAQ:ILMN) Trading Up 5.7% - Time to Buy?Illumina (NASDAQ:ILMN) Trading 5.7% Higher - What's Next?January 15, 2025 | marketbeat.comIllumina partners with Nvidia on AI-powered genomic sequencingJanuary 15, 2025 | msn.comCCLA Investment Management Grows Stock Holdings in Illumina, Inc. (NASDAQ:ILMN)CCLA Investment Management boosted its holdings in Illumina, Inc. (NASDAQ:ILMN - Free Report) by 20.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 535,050 shares of the life sciences company's stock after buying aJanuary 15, 2025 | marketbeat.comIllumina’s Stagnant Revenue Projections and Market Headwinds Justify Sell RatingJanuary 15, 2025 | markets.businessinsider.comIllumina’s Hold Rating: Balancing Revenue Growth with Market UncertaintiesJanuary 15, 2025 | markets.businessinsider.comBernstein Sticks to Their Hold Rating for Illumina (ILMN)January 14, 2025 | markets.businessinsider.comIllumina, Inc. (ILMN) 43rd Annual JPMorgan Healthcare Conference - (Transcript)January 14, 2025 | seekingalpha.comIllumina Raises Q4 Revenue Outlook To $1.10 Billion, Exceeding Street Expectations; Sees Solid MarginsJanuary 14, 2025 | benzinga.comIllumina (NASDAQ:ILMN) Issues Q4 2024 Earnings GuidanceIllumina (NASDAQ:ILMN) updated its fourth quarter 2024 earnings guidance. The company provided EPS guidance of 0.910-0.930 for the period, compared to the consensus estimate of 0.920. The company also issued revenue guidance of $1.1 billionillion-$1.1 billionillion, compared to the consensus estimate of $1.1 billionillion.January 14, 2025 | marketbeat.comIllumina (NASDAQ:ILMN) Issues FY 2024 Earnings GuidanceIllumina (NASDAQ:ILMN) updated its FY 2024 earnings guidance. The company provided EPS guidance of 4.120-4.140 for the period, compared to the consensus estimate of 4.120. The company also issued revenue guidance of $4.3 billionillion-$4.3 billionillion, compared to the consensus estimate of $4.3 billionillion.January 14, 2025 | marketbeat.comIllumina (NASDAQ:ILMN) Issues Q4 Earnings GuidanceIllumina (NASDAQ:ILMN) updated its fourth quarter earnings guidance. The company provided EPS guidance of $0.91-$0.93 for the period, compared to the consensus estimate of $0.92. The company also issued revenue guidance of $1.10 billionillion, compared to the consensus estimate of $1.07 billionillion.January 14, 2025 | marketbeat.comIllumina reports preliminary Q4 results, provides 2025 expectationsJanuary 14, 2025 | seekingalpha.comIllumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2024 and Provides Preliminary Outlook for Fiscal Year 2025January 14, 2025 | prnewswire.comNvidia (NVDA) Expands Healthcare Presence with Illumina PartnershipJanuary 14, 2025 | tipranks.comMorgan Stanley Lowers Illumina (NASDAQ:ILMN) Price Target to $150.00January 14, 2025 | americanbankingnews.comIllumina (ILMN) Receives a Hold from Morgan StanleyJanuary 13, 2025 | markets.businessinsider.comWhy Tech Stocks Dropped MondayJanuary 13, 2025 | investopedia.comIllumina, Nvidia collaborate to decode biology and propel precision healthJanuary 13, 2025 | markets.businessinsider.comIllumina (NASDAQ:ILMN) Stock Price Up 5.7% - Should You Buy?Illumina (NASDAQ:ILMN) Stock Price Up 5.7% - Here's What HappenedJanuary 13, 2025 | marketbeat.comMorgan Stanley Cuts Illumina (NASDAQ:ILMN) Price Target to $150.00Morgan Stanley dropped their price objective on shares of Illumina from $156.00 to $150.00 and set an "equal weight" rating for the company in a research note on Monday.January 13, 2025 | marketbeat.comIllumina launches pilot proteomics program with UK Biobank, collaboratorsJanuary 13, 2025 | markets.businessinsider.comIllumina and NVIDIA collaborate to decode biology and propel precision healthJanuary 13, 2025 | prnewswire.comTruveta sells stakes to Regeneron, Illumina in deal to build genetic databaseJanuary 13, 2025 | investing.comTruveta sells stakes to Regeneron, Illumina in deal to build genetic databaseJanuary 13, 2025 | reuters.comIllumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samplesJanuary 13, 2025 | investing.comIllumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samplesJanuary 13, 2025 | prnewswire.comQ1 Earnings Estimate for Illumina Issued By Leerink PartnrsJanuary 11, 2025 | americanbankingnews.comIllumina price target lowered to $140 from $145 at BernsteinJanuary 10, 2025 | markets.businessinsider.comIllumina Inc (ILMN) to Announce Q4 and Full Year 2024 Financial ResultsJanuary 9, 2025 | gurufocus.comIllumina to Announce Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 6, 2025January 9, 2025 | prnewswire.comQ1 Earnings Forecast for Illumina Issued By Leerink PartnrsIllumina, Inc. (NASDAQ:ILMN - Free Report) - Stock analysts at Leerink Partnrs raised their Q1 2025 earnings per share estimates for shares of Illumina in a research note issued to investors on Tuesday, January 7th. Leerink Partnrs analyst P. Souda now forecasts that the life sciences company wilJanuary 9, 2025 | marketbeat.comDouglas Lane & Associates LLC Buys 4,442 Shares of Illumina, Inc. (NASDAQ:ILMN)Douglas Lane & Associates LLC raised its stake in Illumina, Inc. (NASDAQ:ILMN - Free Report) by 1.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 294,787 shares of the life sciences company's stock afterJanuary 8, 2025 | marketbeat.comQ4 Earnings Estimate for Illumina Issued By Leerink PartnrsIllumina, Inc. (NASDAQ:ILMN - Free Report) - Research analysts at Leerink Partnrs cut their Q4 2025 earnings per share (EPS) estimates for shares of Illumina in a research report issued to clients and investors on Tuesday, January 7th. Leerink Partnrs analyst P. Souda now forecasts that the lifeJanuary 8, 2025 | marketbeat.comIllumina launches update to its NovaSeq X Series softwareJanuary 8, 2025 | markets.businessinsider.comIllumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applicationsJanuary 7, 2025 | prnewswire.comAlibaba: Shedding Sun Art To Illuminate E-CommerceJanuary 5, 2025 | seekingalpha.comIllumina price target lowered to $180 from $184 at Evercore ISIJanuary 2, 2025 | markets.businessinsider.comShort Interest in Illumina, Inc. (NASDAQ:ILMN) Drops By 9.7%Illumina, Inc. (NASDAQ:ILMN - Get Free Report) was the target of a significant decline in short interest in December. As of December 15th, there was short interest totalling 6,510,000 shares, a decline of 9.7% from the November 30th total of 7,210,000 shares. Based on an average daily trading volume, of 2,080,000 shares, the days-to-cover ratio is presently 3.1 days.January 1, 2025 | marketbeat.comIllumina Inc. stock underperforms Tuesday when compared to competitors despite daily gainsJanuary 1, 2025 | marketwatch.com Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Email Address ILMN Media Mentions By Week ILMN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ILMN News Sentiment▼0.450.44▲Average Medical News Sentiment ILMN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ILMN Articles This Week▼3113▲ILMN Articles Average Week Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Agilent Technologies News Mettler-Toledo International News Waters News Bio-Techne News Bio-Rad Laboratories News Bruker News Charles River Laboratories International News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ILMN) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Illumina, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Illumina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
